HI TECH PHARMACAL CO INC - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - December 7, 2012

Attached files
FileFilename
EXCEL - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCFinancial_Report.xls
10-Q - FORM 10-Q - HI TECH PHARMACAL CO INCd399017d10q.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR7.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR6.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR8.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR2.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR5.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR3.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR4.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR1.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR9.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR49.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR23.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR40.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR38.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR27.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR34.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR50.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR28.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR21.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR17.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR16.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR48.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR55.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR37.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR56.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR31.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR29.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR15.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR32.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR13.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR54.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR10.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR43.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR18.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR53.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR12.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR35.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR36.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR19.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR42.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR24.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR45.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR25.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR46.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR20.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR41.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR22.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR11.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR39.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR47.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR26.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR44.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR14.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR52.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR33.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR51.htm
EX-32 - EX-32 - HI TECH PHARMACAL CO INCd399017dex32.htm
EX-31.2 - EX-31.2 - HI TECH PHARMACAL CO INCd399017dex312.htm
EX-31.1 - EX-31.1 - HI TECH PHARMACAL CO INCd399017dex311.htm
v2.4.0.6
Stock-Based Compensation (Tables)
 6 Months Ended
Oct. 31, 2012
Stock-Based Compensation [Abstract]  
Schedule of stock option plans and employee stock purchase plan

The Company recognized stock-based compensation for awards issued under the Company’s Stock Option Plans and Employee Stock Purchase Plan in the following line items in the condensed consolidated statements of operations:

 

                                 
    Three months ended October 31,     Six months ended October 31,  
    2012     2011     2012     2011  

Cost of goods sold

   $ 125,000     $ 87,000     $ 217,000     $ 174,000  

Selling, general and administrative expenses

     735,000       571,000       1,271,000       1,137,000  

Research and product development costs

     181,000       83,000       338,000       166,000  
   

 

 

    

 

 

    

 

 

    

 

 

  

Stock-based compensation expense

   $ 1,041,000     $ 741,000     $ 1,826,000     $ 1,477,000  
   

 

 

    

 

 

    

 

 

    

 

 

  
Weighted average assumptions used for the stock options granted

The following weighted average assumptions were used for the stock options granted during the six months ended October 31, 2012:

 

                 
    July 16, 2012     August 1, 2012  

Dividend yield

     None       None  

Expected volatility

     54 %      54 % 

Risk-free interest rate

     0.60 %      0.60 % 

Expected term

     4.00       4.00  

Weighted average fair value per share at grant date

   $ 13.62     $ 13.79  

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA


This web site and associated pages are not associated with, endorsed by, or sponsored by HI TECH PHARMACAL CO INC and has no official or unofficial affiliation with HI TECH PHARMACAL CO INC


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.